Future challenges of multimodality imaging

Recent Results in Cancer Research

Volumn 187, Issue , 2013, Pages 403-415

  Estorch, Montserrat ^a   Carrio, Ignasi ^a  

^a Hospital Sant Pau   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE C 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; TRACER; WATER O 15;

ARTICLE; BIOLUMINESCENCE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; HUMAN; IMAGE QUALITY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TREATMENT RESPONSE; METHODOLOGY; REVIEW;

DIAGNOSTIC IMAGING; HUMANS;

EID: 84871846247     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-10853-2_14     Document Type: Article

References (56)

1. Anger HO (1957) Scintillation camera. Rev Sci Instrum 29:27-33
2. Bading JR, Shields AF (2008) Imaging of cell proliferation: status and prospects. J Nucl Med 49:64S-80S
3. Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200-1209
4. Bennett CF, Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50:259-293
5. Bentolila LA, Ebenstein Y, Weiss S (2009) Quantum dots for in vivo small-animal imaging. J Nucl Med 50:493-496
6. Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369-1379
7. Bouchelouche K, Oehr P (2008) Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: An update review. J Urol 179:34-45
8. 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617-1626
9. Bundschuh R, Martínez-Möller A, Essler M et al (2008) Local motion correction for lung tumours in PET/CT-First results. Eur J Nucl Med Mol Imaging 35:1981-1988
10. Catana C, Procissi D, Wu YB et al (2008) Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci USA 105:3705-3710
11. Chakrabarti A, Aruva MR, Sajankila SP (2005) Synthesis of novel peptide nucleic acid-peptide chimera for non-invasive imaging of cancer. Nucleosides Nucleotides Nucleic Acids 24:409-414
12. Chakrabarti A, Zhang K, Aruva MR et al (2007) Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [64Cu]DO3A-peptide nucleic acid-peptide nanoparticles. Cancer Biol Ther 6:948-956
13. Chang G, Chang T, Pan T, Clark JW Jr, Mawlawi OR (2010) Implementation of an automated respiratory amplitude gating technique for PET/CT: clinical evaluation. J Nucl Med 51:16-24
14. Cheng NM, Yu CT, Ho KC, Wu YC, Liu YC, Wang CW, Yen TC(2009)Respiration- averagedCTfor attenuation correction in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 36:607-615
15. Cherry SR (2004) In vivo molecular and genomic imaging: new challenges for imaging physics. Phys Med Biol 49:R13-R48
16. Cherry SR, Louie AY, Jacobs RE (2008) The integration of positron emission tomography with magnetic resonance imaging. Proc IEEE 96:416-438
17. Czernin J, Allen-Auerbach M, Schelbert HR (2007) Improvements in cancer staging with PET/ CT: literature-based evidence as of september 2006. J Nucl Med 48:78S-88S
18. Despres P, Funk T, Shah KS et al (2007) Monte Carlo simulations of compact gamma cameras based on avalanche photodiodes. Phys Med Biol 52:3057-3074
19. Erickson SJ, Ge J, Sanchez A, Godavarty A (2010) Two-dimensional fast surface imaging using a handheld optical device: in vitro and in vivo fluorescence studies. Transl Oncol 3:16-22
20. Faria SL, Menard S, Devic S, Sirois C, Souhami L, Lisbona R, Freeman CR (2008) Impact of FDGPET/ CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. Int J Radiat Oncol Biol Phys 70:1035-1038
21. Freudenberg LS, Antoch G, Frilling A et al (2008) Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950-977
22. Germano PM, Le SV, Oh DS et al (2004) Differential coupling of PAC1 SV1 splice variant of human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation. J Mol Neurosci 22:83-92
23. Gerth HU, Juergens KU, Dirksen U et al (2007) Significant benefit of multimodal imaging: PET/ CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med 48:1932-1939
24. Goerres GW, Stupp R, Barghouth G et al (2005) The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 32:153-162
25. 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 73:759-763
26. Hersey P, Bastholt L, Chiarion-Sileni V, Cinat G, Dummer R, Eggermont AM, Espinosa E, Hauschild A, Quirt I, Robert C, Schadendorf D (2009) Small molecules and targeted therapies in distant metastatic disease. Ann Oncol 20:(Suppl6) vi35-40
27. Hicks RJ, Rischin D, Fisher R et al (2005) Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 32:1384-1391
28. Hofmann M, Steinke F, Scheel V et al (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875-1883
29. Hu R, Yong K-T, Roy I, Ding H, He S, Prasad PN (2009) Metallic nanostructures as localized plasmon resonance enhanced scattering probes for multiplex dark field targeted imaging of cancer cells. J Phys Chem C Nanomater Interfaces 113:2676-2684
30. Jentzen W, Freudenberg L, Eising EG et al (2008a) Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer. J Nucl Med 49:1017-1023
31. Jentzen W, Weise R, Kupferschläger J et al (2008b) Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Eur J Nucl Med Mol Imaging 35:611-623
32. Judenhofer MS, Wehrl HF, Newport DF et al (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14:459-465
33. Kirui DK, Rey DA, Batt CA (2010) Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 21:1-10
34. Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E (2010) Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy. Radiology 254:277-284
35. la Fougère C, Hundt W, Bröckel N et al (2006) Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 33:1417-1425
36. Lendvai G, Estrada S, Bergström M (2009) Radiolabelled oligonucleotides for imaging of gene expression with PET. Curr Med Chem 16:4445-4461
37. Panin VY, Kehren F, Michel C et al (2006) Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging 25:907-921
38. Patton JA, Townsend DW, Hutton BF (2009) Hybrid imaging technology: from dreams and vision to clinical devices. Semin Nucl Med 39:247-263
39. Peter J, Semmler W (2006) Performance investigation of a dual-modality SPECT/optical small animal imager. Eur J Nucl Med Mol Imaging 33:S117-S117
40. Raanani P, Shasha Y, Perry C et al (2006) Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol 17:117-122
41. 18F-]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 30:695-704
42. Raylman RR, Majewski S, Lemieux SK et al (2006) Simultaneous MRI and PET imaging of a rat brain. Phys Med Biol 51:6371-6379
43. 18F]fluorothymidine. Semin Nucl Med 37:429-439
44. Schlemmer HPW, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028-1035
45. Schulz S, Rocken C, Mawrin C et al (2004) Immunocytochemical identification of VPAC1, VPAC2 and PAC1 receptors in normal and neoplastic human tissues with subtype specific antibodies. Clin Cancer Res 10:8234-8242
46. Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC (2009) Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. Clin Cancer Res 15:4712-4721
47. 18F-FLT and positron emission tomography. Nat Med 4:1334-1336
48. Tan PH, Bay BH, Yip G et al (2005) Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 18:374-381
49. 99mTc-peptide-peptide nucleic acidpeptide chimeras. J Nucl Med 45:2070-2082
50. Tian X, Aruva MR, Wolfe HR et al (2005) Tumor-targeting peptide-PNA peptide chimeras for imaging overexpressed oncogene mRNAs. Nucleosides Nucleotides Nucleic Acids 24:1085-1091
51. Tian X, Aruva MR, Zhang K et al (2007) PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu] chelatorpeptide nucleic acid-IGF1 analog radiohybridization probes. J Nucl Med 48:1699-1707
52. Townsend DW (2008) Multimodality imaging of structure and function. Phys Med Biol 53:R1-R39
53. Vu NT, Silverman RW, Chatziioannou AF (2006) Preliminary performance of optical PET (OPET) detectors for the detection of visible light photons. Nucl Instrum Methods 569:563-566
54. 11C] thymidine positron emission tomography in advanced intra-abdominal malignancies. Cancer Res 62:5698-5702
55. Woody C, Schlyer D, Vaska P et al (2007) Preliminary studies of a simultaneous PET/MRI scanner based on the RatCAP small animal tomograph. Nucl Instrum Methods A 571:102-105
56. Zaidi H., Is MR-guided attenuation correction a viable option for dualmodality PET/MR imaging?. Radiology. 2007 (244), 639-642.